LivaNova PLC products

Three Components, One Integrated Solution for Acute Respiratory Failure. The HEMOLUNG is the world’s first and only fully-integrated, FDA cleared system for extracorporeal CO2 removal (ECCO2R). The HEMOLUNG removes carbon dioxide directly from the blood at blood flow rates between 350 – 550 mL/min which can mitigate the harmful effects of hypercapnia, respiratory acidosis, intubation and ventilator induced lung injuries. The HEMOLUNG is an innovative tool to manage acute respiratory failure while minimizing the risks and complexities of extracorporeal lung support.

Addresses the difficulty of inadequate exposure during MICS procedures.

Low profile design to decrease the footprint, increase access and enhance working space and field organization efficiencies during MICS procedures. Triple-segmented arm design enables contouring consistency with underlying anatomical and operative site variability. Bilateral arm movement promotes equivalent distribution of incremental retraction within the intercostal space. Minimized gear spacing enhances control and precision of incremental retraction within the intercostal space.

Low profile design lo decrease the fooipiint. increase access and enhance working space and field organisation efficiencies during MiCS procedures. Triple-icgmenled a»m design enables contouring consistency with underlying anatomical end operative  variably. Bilateral arm movement promote! equnafent distribution of incremental retraction within the intercostal space. Minimised gear spacing enhances control and precision o* incremental retraction within the intercostal space.

The TandemLife Kit takes the complexity out of emergent rescue. The easy-to-prime pump and oxygenator enable you to stabilize the patient quickly. Emergent severe life-threatening events, such as sudden cardiac arrest, severe respiratory distress, or traumas requiring immediate life-support, will strike more than a million Americans each year at any time or in any place. When these events occur, a rapid, easy to use device may be essential to survival. The market is already trending in this direction, but current temporary cardiopulmonary bypass systems have a level of complexity that may inhibit the use of the device.

For more patients, in more places. Built on more than 20 years of life support experience with TandemLife, LifeSPARC provides temporary support for emergent rescue patients in a variety of hospital settings.

Unique Design: Venous and arterial cannulae feature suture wings to securely attach to the patient, and the arterial cannula has a rubber stopper to reduce the risk over insertion.

Simplified Patient Management: The small but powerful pump can be used in the Cardiac Catherization Lab or the Operating Room. Simplify patient management with the world’s only sterile on-patient pump.

Patented Flow Technology: The simplified design features patented radial flow technology lowering flow resistance, enabling the pump to move blood more efficiently.

Rapid Initiation of Support: The unique sterile priming basin uses gravity for a rapid, repeatable priming process. This plug-and-play design allows the system to be primed within 5 minutes.